PortfoliosLab logo
CARA vs. QQQM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CARA and QQQM is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

CARA vs. QQQM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cara Therapeutics, Inc. (CARA) and Invesco NASDAQ 100 ETF (QQQM). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%NovemberDecember2025FebruaryMarchApril
-96.31%
65.45%
CARA
QQQM

Key characteristics

Sharpe Ratio

CARA:

-0.24

QQQM:

0.46

Sortino Ratio

CARA:

0.48

QQQM:

0.81

Omega Ratio

CARA:

1.06

QQQM:

1.11

Calmar Ratio

CARA:

-0.29

QQQM:

0.51

Martin Ratio

CARA:

-0.54

QQQM:

1.73

Ulcer Index

CARA:

52.52%

QQQM:

6.67%

Daily Std Dev

CARA:

120.13%

QQQM:

24.98%

Max Drawdown

CARA:

-99.17%

QQQM:

-35.05%

Current Drawdown

CARA:

-98.26%

QQQM:

-12.28%

Returns By Period

In the year-to-date period, CARA achieves a -0.61% return, which is significantly higher than QQQM's -7.43% return.


CARA

YTD

-0.61%

1M

18.11%

6M

87.74%

1Y

-25.92%

5Y*

-50.15%

10Y*

-26.31%

QQQM

YTD

-7.43%

1M

0.74%

6M

-4.32%

1Y

10.36%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CARA vs. QQQM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CARA
The Risk-Adjusted Performance Rank of CARA is 4343
Overall Rank
The Sharpe Ratio Rank of CARA is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of CARA is 5252
Sortino Ratio Rank
The Omega Ratio Rank of CARA is 5252
Omega Ratio Rank
The Calmar Ratio Rank of CARA is 3434
Calmar Ratio Rank
The Martin Ratio Rank of CARA is 4141
Martin Ratio Rank

QQQM
The Risk-Adjusted Performance Rank of QQQM is 5858
Overall Rank
The Sharpe Ratio Rank of QQQM is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of QQQM is 5858
Sortino Ratio Rank
The Omega Ratio Rank of QQQM is 5757
Omega Ratio Rank
The Calmar Ratio Rank of QQQM is 6363
Calmar Ratio Rank
The Martin Ratio Rank of QQQM is 5656
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CARA vs. QQQM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cara Therapeutics, Inc. (CARA) and Invesco NASDAQ 100 ETF (QQQM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CARA, currently valued at -0.21, compared to the broader market-2.00-1.000.001.002.003.00
CARA: -0.21
QQQM: 0.46
The chart of Sortino ratio for CARA, currently valued at 0.55, compared to the broader market-6.00-4.00-2.000.002.004.00
CARA: 0.55
QQQM: 0.81
The chart of Omega ratio for CARA, currently valued at 1.08, compared to the broader market0.501.001.502.00
CARA: 1.08
QQQM: 1.11
The chart of Calmar ratio for CARA, currently valued at -0.25, compared to the broader market0.001.002.003.004.005.00
CARA: -0.25
QQQM: 0.51
The chart of Martin ratio for CARA, currently valued at -0.46, compared to the broader market-5.000.005.0010.0015.0020.00
CARA: -0.46
QQQM: 1.73

The current CARA Sharpe Ratio is -0.24, which is lower than the QQQM Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of CARA and QQQM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.21
0.46
CARA
QQQM

Dividends

CARA vs. QQQM - Dividend Comparison

CARA has not paid dividends to shareholders, while QQQM's dividend yield for the trailing twelve months is around 0.64%.


TTM20242023202220212020
CARA
Cara Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
QQQM
Invesco NASDAQ 100 ETF
0.64%0.61%0.65%0.83%0.40%0.16%

Drawdowns

CARA vs. QQQM - Drawdown Comparison

The maximum CARA drawdown since its inception was -99.17%, which is greater than QQQM's maximum drawdown of -35.05%. Use the drawdown chart below to compare losses from any high point for CARA and QQQM. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-98.26%
-12.28%
CARA
QQQM

Volatility

CARA vs. QQQM - Volatility Comparison

Cara Therapeutics, Inc. (CARA) has a higher volatility of 20.74% compared to Invesco NASDAQ 100 ETF (QQQM) at 16.54%. This indicates that CARA's price experiences larger fluctuations and is considered to be riskier than QQQM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%70.00%NovemberDecember2025FebruaryMarchApril
20.74%
16.54%
CARA
QQQM